LUIS
CAMINAL MONTERO
Investigador/a
Hospital de Fuenlabrada
Fuenlabrada, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Fuenlabrada (3)
2023
-
Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients
Medicina (Kaunas, Lithuania), Vol. 59, Núm. 8
2016
-
Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies
Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 4, pp. 391-399
2011
-
Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label
Arthritis Research and Therapy, Vol. 13, Núm. 4